Subscribe to stay informed!
Exton-based Immunome has reported positive results from testing its antibody cocktail against live versions of the omicron variant of COVID-19. John George broke…
Immunome saw its stock soar after the Exton-based company discovered antibodies that have shown, in early testing, the ability to neutralize multiple variants of…
Immunome, an Exton-based biopharmaceutical company, went public last week and managed to raise $39 million through an upsized initial public stock offering, writes John…
Before we send you to this site, please subscribe to our daily newsletter.